Global

‡ In these countries please contact our distributor

Our strategy

In December 2021 we announced our Strategy for Growth. Through this we will compound our outperformance in Advanced Wound Management and Sports Medicine & ENT, and regain momentum in Orthopaedics. Our ambition is to transform to a structurally higher growth company.

Our Strategy for Growth is based on three pillars. 

  • First we will Strengthen the foundations of Smith+Nephew. A solid base in commercial and manufacturing will enable us to serve customers sustainably and simply, and deliver the best from our core portfolio.
  • Second, we will Accelerate our growth profitably, through more robust prioritisation of resources and investment, and with continuing customer focus.
  • Third we will continue to Transform ourselves for higher long-term growth, through investment in innovation and acquisitions.

The Strategy for Growth will be delivered through the four key value builders of productivity, commercial execution, innovation and acquisitions. 

Purpose and Culture

We care, we collaborate and we have courage as we work to help people live Life Unlimited. Read more about our purpose and culture.